FDA Adverse Event Injury Summary report: N

UNK

MDR report key: 24979276 · Received April 24, 2026

Report

Report Number
1220246-2026-02420
Event Type
Injury
Date Received
April 24, 2026
Date of Event
July 1, 2025
Report Date
April 24, 2026
Manufacturer
ARTHREX, INC.
Product Code
PHX
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
501

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE PROVIDED UPON AVAILABILITY OF ADDITIONAL INFORMATION.

Description of Event or Problem · 0

ON 02-APR-2026, ARTHREX WAS NOTIFIED VIA EMAIL OF A CASE STUDY PUBLISHED IN 2025 BY THE JOURNAL OF SHOULDER AND ELBOW SURGERY, TITLED ¿EFFECT OF LATERALIZATION AND DISTALIZATION ON TUBEROSITY HEALING AND FUNCTIONAL OUTCOMES AFTER REVERSE TOTAL SHOULDER ARTHROPLASTY WITH UNIVERS REVERS TOTAL SHOULDER SYSTEM FOR PROXIMAL HUMERUS FRACTURES: A RANDOMIZED CONTROLLED TRIAL COMPARING 135° AND 155° UNCEMENTED STEMS". THE STUDY REVIEWED ONE SEVENTY-SIX (76) PATIENTS WHO UNDERWENT REVERSE TOTAL SHOULDER ARTHROPLASTY (RTSA) TO ADDRESS ACUTE (<3 WEEKS) NEER 3- OR 4-PART PHF, HEAD SPLIT FRACTURE, OR A DISPLACED NEER 2-PART PHF WITH OSTEOPOROSIS AND/OR A ROTATOR CUFF TEAR, USING ARTHREX UNIVERSAL GLENOID DEVICES. DURING THE MINIMUM TWO (2) YEAR FOLLOW-UP PERIOD, ONE (1) PATIENT EXPERIENCED ACROMION FRACTURE/ACROMION STRESS FRACTURE. SOURCE: RIUS, X., GONZALEZ-MORGADO, D., MATELLANES, J., LUZARDO, A., AGULLO, J. L., & HACHEM, A. I. (2025). EFFECT OF LATERALIZATION AND DISTALIZATION ON TUBEROSITY HEALING AND FUNCTIONAL OUTCOMES AFTER REVERSE TOTAL SHOULDER ARTHROPLASTY WITH UNIVERS REVERS TOTAL SHOULDER SYSTEM FOR PROXIMAL HUMERUS FRACTURES: A RANDOMIZED CONTROLLED TRIAL COMPARING 135° AND 155° UNCEMENTED STEMS. JOURNAL OF SHOULDER AND ELBOW SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
222460 UNK SHOULDR PROSTH, REVERSE CONFIG PHX ARTHREX, INC. UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other